Drug Search Results
More Filters [+]

Roxatidine

Alternative Names: roxatidine
Latest Update: 2024-12-19
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: H2 Antagonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Bangladesh | India | Ireland | Italy | Japan | Korea | Portugal | South Africa | Taiwan | Venezuela

Approved Indications: None

Known Adverse Events: None

Company: Sihuan Pharmaceutical
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Roxatidine

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

CTR20200196

N/A

Completed

Edema|Gastritis|Duodenal Ulcer|Zollinger-Ellison Syndrome|Duodenal Diseases|Esophagitis

2020-09-04

CTR20190618

N/A

Completed

Duodenal Ulcer|Esophagitis|Duodenal Diseases|Edema|Gastritis

2019-05-08

Recent News Events